Philip Gerken

Philip Gerken serves as a Principal Scientist in Medicinal Chemistry at Schrödinger since May 2023. Prior to this role, Philip Gerken was a Senior Scientist in Medicinal Chemistry at Frontier Medicines from October 2021 to April 2023. Earlier experience includes positions at Theravance Biopharma US, Inc., where Philip Gerken held titles of Research Scientist, Scientist, and Postdoctoral Researcher from March 2017 to October 2021. Philip Gerken earned a Doctor of Philosophy (PhD) in Chemistry from the University of Oxford, where studies were completed from 2012 to 2017, following a Master of Chemistry (MChem) also from the University of Oxford from 2008 to 2012.